PMCB
PMCB
NASDAQ · Biotechnology

Pharmacyte Biotech Inc

$0.40
0.00 (-0.77%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +6,849.9% upside
Low Target $20.43
Average Target $27.73
High Target $35.07
Current Price $0.40
Current
$0.40
Target
$27.73
$20.43 $27.73 avg $35.07
Scenario Analysis
Bear Case
$20.43
5,020.3%
Low target
Base Case
$27.73
+6,849.9%
Avg target
Bull Case
$35.07
+8,689.5%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$1.51
-73.6% from high
52-Week Low
$0.30
+32.1% from low
Target vs 52W High
$27.73
+1,736.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%